Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Hudbay Exploration Review Webcast

<< Previous

Bullboard Posts

Next >>

Comment by The300on Dec 22, 2010 9:56pm

283 Views

Post# 17886337

RE: RE: Hudbay Exploration Review Webcast

Good evening Guerreiro,

Unfortunately I'm not privy to the timeline of the private placement. i would imagine with the holiday season that wrapping up the private placement may have taken a little longer than anticipated. That being said, I would image that we will see some type of announcement before the week is out.

Once we have the private placement out of the way, I believe that the real fun will begin.

i'm looking forward to the New Year.

Regards,

The 300

<< Previous

Bullboard Posts

Next >>

Investor’s corner: Solving chronic pain in dogs – A significant market opportunity